|
TOP NEWS
CareFirst Says Intent Standard Was Misread In Stelara Case
By Jared Foretek
CareFirst is arguing that a Virginia federal judge created a new standard for monopolization claims when he dismissed claims from the company's antitrust suit challenging Johnson & Johnson's protection of its immunosuppressive drug Stelara, arguing he misread a Fourth Circuit decision in ruling that monopolization requires a showing of specific intent.
Brief attached |
Read full article »
| Save to favorites »
MERGER REVIEW
LITIGATION
Judge Tosses XAI Trade Secret Case Against OpenAI
By Ivan Moreno
A California federal judge on Monday dismissed xAI Corp.'s trade secret lawsuit against OpenAI without leave to amend, finding that despite updating its complaint once previously, the company still failed to plausibly allege that OpenAI knowingly obtained or used confidential information from former xAI employees.
Order attached |
Read full article »
| Save to favorites »
POLICY & REGULATION
EXPERT ANALYSIS
Meta's AI Deals Test Scope Of China M&A Scrutiny
The Chinese government's recent approval of Meta's purchase of an AI and robotics company, shortly after blocking a similar deal, raises questions about how far China's legal authority extends over foreign companies connected to China, and highlights the regulatory and compliance risks involved in cross-border acquisitions of AI businesses, says Minda Huang at TsingLaw Partners.
Read full article »
| Save to favorites »
LEGAL INDUSTRY
|